Psychotropic medication use and clinical outcomes among children and adolescents receiving system of care services

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 1, 2013, Pages 36-43

  Drilea, Susan K ^a   Jowers, Keri ^a   Lichtenstein, Carolyn ^a   Hale, Malcolm ^a   Blau, Gary ^b   Stromberg, Susan ^b  

^a Walter R McDonald and Associates Inc   (United States)

^b SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIOR DISORDER; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EMOTIONAL DISORDER; EVALUATION; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; POVERTY; PRESCHOOL CHILD; RESIDENTIAL CARE; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADOLESCENT BEHAVIOR; CHILD; CHILD BEHAVIOR; COMMUNITY MENTAL HEALTH SERVICES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; UNITED STATES;

EID: 84874067510     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0026     Document Type: Article

References (33)

1. Achenbach T, Rescorla L: Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families; 2001
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edi. (DSM-IV). Washington, DC: American Psychiatric Association; 1994
3. Center for Health Services Research on Pharmacotherapy, Chronic Disease Management and Outcomes Website, Rutgers University: Available at www.ihhcpar.rutgers.edu/org-units/default.asp?v=2& o=27. Accessed May 17, 2010
4. Coletti DJ, Leigh E, Gallelli KA, Kafantaris V: Patterns of adherence to treatment in adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 15:913-917, 2005
5. Emslie GJ, Mayes TL, Laptook RS, Batt M: Predictors of response to treatment in children and adolescents with mood disorders. Psychiatr Clin North Am 26:435-456, 2003
6. Fontanella CA, Bridge JA, Campo JV: Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients. Ann Pharmacother 43:1939-1947, 2009
7. Frank RG, Glied SA: Better but Not Well: Mental Health Policy in the United States since 1950. Baltimore: Johns Hopkins University Press; 2006
8. Froehlich TE, Lamphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS: Prevalence, recognition, and treatment of attentiondeficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 161:857-864, 2007
9. Hudson JL, Miller GE, Kirby, JB: Explaining racial and ethnic differences in children's use of stimulant medications. Med Care 45:1068-1075, 2007
10. Ipser JC, Stein DJ, Hawkridge S, Hoppe L: Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 3:CD005170, 2009
11. Jacobson NS, Truax P: Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12-19, 1991
12. Jerrell JM: Pharmacotherapy in the community-based treatment of children with bipolar I disorder. Hum Psychopharmacol 23: 53-59, 2008
13. Julius RJ, Novitsky MA Jr, Dubin WR: Medication adherence: A review of the literature and implications for clinical practice. J Psychiatr Pract 15:34-44, 2009
14. Kapczinski FFK, Silva de Lima M, dos Santos Souza JJSS, Batista Miralha da Cunha AABC, Schmitt RRS: Antidepressants for generalized anxiety disorder. Cochrane Database of Syst Rev 2: CD003592, 2003
15. Leslie L, Weckerly J, Landsverk J, Hough R, Hurlburt M, Wood P: Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. J Am Acad Child Adolesc Psychiatry 42:1433-1442, 2003
16. Martin A, Leslie D: Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000 Am J Psychiatry 160:757-764, 2003
17. Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L: Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 54:72-77, 2003
18. Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abvikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR, MTA Cooperative Group: The MTA at 8 years: Prospective follow-up of children treated for combined-Type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48:484-500, 2009
19. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 64:1032-1039, 2007
20. National Community Pharmacists Association: Take as directed: A prescription not followed. Press release. Available at www.ncpanet .org/media/releases/2006/take-as-directed.php. Accessed May 14, 2010
21. Olfson M, Blanco C, Liu L, Moreno C, Laje G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63:679-685, 2006
22. Pavkov TW, Walrath CM: Clinical and non-clinical characteristics associated with medication use among children with serious emotional disturbance. J Child Fam Stud 17:839-852, 2008
23. Riddle M, Kastelic E, Frosch E: Pediatric psychopharmacology. J Child Psychol Psychiatry 42:73-90, 2001
24. Teich JL, Buck JA, Graver D, Schroeder D, Zheng D: Utilization of public mental health services by children with serious emotional disturbances. Adm Policy Ment Health 30:523-534, 2003
25. United States Department of Health and Human Services (US DHHS): HHS Poverty Guidelines. Available at aspe.hhs.gov/poverty/figures-fed-reg.shtml. Accessed December 12, 2009
26. United States Public Health Service: Report of the Surgeon General's Conference on Children's Mental Health: A National Action Agenda. Washington, DC: Department of Health and Human Services, 2000
27. Visser SN, Lesesne CA, Perou R: National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics 119:S99-S106, 2007
28. Warner LA, Pottick KJ, Bilder SM: Clinical and organizational correlates of medication for youths in U.S. mental health services. Soc Serv Rev 454-481, 2005
29. Warner LA, Pottick KJ, Mukherjee A: Use of psychotropic medications by youths with psychiatric diagnoses in the U.S. mental health system. Psychiatr Serv 55:309-311, 2004
30. Wolraich ML: Annotation: The use of psychotropic medications in children: An American view. J Child Psychol Psychiatry 44:150-168, 2003
31. Zito JM, Safer DJ: Sources of data for pharmacoepidemiological studies of child and adolescent psychiatric disorders. J Child Adolesc Psychopharmacol 7:237-253, 1997
32. Zito JM, Safer DJ: Recent child pharmacoepidemiological findings. J Child Adolesc Psychopharmacol 15:5-9, 2005
33. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle M: Psychotropic practice patterns for youth: A 10-year perspective. Arch Pediatr Adolesc Med 157:17-25, 2003